Increased hippocampal neurogenesis in Alzheimer's disease

Kunlin Jin, Alyson L. Peel, Xiao Ou Mao, Lin Xie, Barbara A. Cottrell, David C. Henshall, David A. Greenberg

Research output: Contribution to journalArticle

763 Citations (Scopus)

Abstract

Neurogenesis, which persists in the adult mammalian brain, may provide a basis for neuronal replacement therapy in neurodegenerative diseases like Alzheimer's disease (AD). Neurogenesis is increased in certain acute neurological disorders, such as ischemia and epilepsy, but the effect of more chronic neurodegenerations is uncertain, and some animal models of AD show impaired neurogenesis. To determine how neurogenesis is affected in the brains of patients with AD, we investigated the expression of immature neuronal marker proteins that signal the birth of new neurons in the hippocampus of AD patients. Compared to controls, Alzheimer's brains showed increased expression of doublecortin, polysialylated nerve cell adhesion molecule, neurogenic differentiation factor and TUC-4. Expression of doublecortin and TUC-4 was associated with neurons in the neuroproliferative (subgranular) zone of the dentate gyrus, the physiological destination of these neurons (granule cell layer), and the CA1 region of Ammon's horn, which is the principal site of hippocampal pathology in AD. These findings suggest that neurogenesis is increased in AD hippocampus, where it may give rise to cells that replace neurons lost in the disease, and that stimulating hippocampal neurogenesis might provide a new treatment strategy.

Original languageEnglish
Pages (from-to)343-347
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume101
Issue number1
DOIs
StatePublished - 1 Jan 2004

Fingerprint

Neurogenesis
Alzheimer Disease
Neurons
Hippocampus
Brain
Dentate Gyrus
Cell Adhesion Molecules
Nervous System Diseases
Neurodegenerative Diseases
Epilepsy
Ischemia
Animal Models
Parturition
Pathology
Therapeutics
Proteins

Cite this

Jin, Kunlin ; Peel, Alyson L. ; Mao, Xiao Ou ; Xie, Lin ; Cottrell, Barbara A. ; Henshall, David C. ; Greenberg, David A. / Increased hippocampal neurogenesis in Alzheimer's disease. In: Proceedings of the National Academy of Sciences of the United States of America. 2004 ; Vol. 101, No. 1. pp. 343-347.
@article{67ab6dec26bc48f69f165d3e525fba89,
title = "Increased hippocampal neurogenesis in Alzheimer's disease",
abstract = "Neurogenesis, which persists in the adult mammalian brain, may provide a basis for neuronal replacement therapy in neurodegenerative diseases like Alzheimer's disease (AD). Neurogenesis is increased in certain acute neurological disorders, such as ischemia and epilepsy, but the effect of more chronic neurodegenerations is uncertain, and some animal models of AD show impaired neurogenesis. To determine how neurogenesis is affected in the brains of patients with AD, we investigated the expression of immature neuronal marker proteins that signal the birth of new neurons in the hippocampus of AD patients. Compared to controls, Alzheimer's brains showed increased expression of doublecortin, polysialylated nerve cell adhesion molecule, neurogenic differentiation factor and TUC-4. Expression of doublecortin and TUC-4 was associated with neurons in the neuroproliferative (subgranular) zone of the dentate gyrus, the physiological destination of these neurons (granule cell layer), and the CA1 region of Ammon's horn, which is the principal site of hippocampal pathology in AD. These findings suggest that neurogenesis is increased in AD hippocampus, where it may give rise to cells that replace neurons lost in the disease, and that stimulating hippocampal neurogenesis might provide a new treatment strategy.",
author = "Kunlin Jin and Peel, {Alyson L.} and Mao, {Xiao Ou} and Lin Xie and Cottrell, {Barbara A.} and Henshall, {David C.} and Greenberg, {David A.}",
year = "2004",
month = "1",
day = "1",
doi = "10.1073/pnas.2634794100",
language = "English",
volume = "101",
pages = "343--347",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "1",

}

Increased hippocampal neurogenesis in Alzheimer's disease. / Jin, Kunlin; Peel, Alyson L.; Mao, Xiao Ou; Xie, Lin; Cottrell, Barbara A.; Henshall, David C.; Greenberg, David A.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 101, No. 1, 01.01.2004, p. 343-347.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Increased hippocampal neurogenesis in Alzheimer's disease

AU - Jin, Kunlin

AU - Peel, Alyson L.

AU - Mao, Xiao Ou

AU - Xie, Lin

AU - Cottrell, Barbara A.

AU - Henshall, David C.

AU - Greenberg, David A.

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Neurogenesis, which persists in the adult mammalian brain, may provide a basis for neuronal replacement therapy in neurodegenerative diseases like Alzheimer's disease (AD). Neurogenesis is increased in certain acute neurological disorders, such as ischemia and epilepsy, but the effect of more chronic neurodegenerations is uncertain, and some animal models of AD show impaired neurogenesis. To determine how neurogenesis is affected in the brains of patients with AD, we investigated the expression of immature neuronal marker proteins that signal the birth of new neurons in the hippocampus of AD patients. Compared to controls, Alzheimer's brains showed increased expression of doublecortin, polysialylated nerve cell adhesion molecule, neurogenic differentiation factor and TUC-4. Expression of doublecortin and TUC-4 was associated with neurons in the neuroproliferative (subgranular) zone of the dentate gyrus, the physiological destination of these neurons (granule cell layer), and the CA1 region of Ammon's horn, which is the principal site of hippocampal pathology in AD. These findings suggest that neurogenesis is increased in AD hippocampus, where it may give rise to cells that replace neurons lost in the disease, and that stimulating hippocampal neurogenesis might provide a new treatment strategy.

AB - Neurogenesis, which persists in the adult mammalian brain, may provide a basis for neuronal replacement therapy in neurodegenerative diseases like Alzheimer's disease (AD). Neurogenesis is increased in certain acute neurological disorders, such as ischemia and epilepsy, but the effect of more chronic neurodegenerations is uncertain, and some animal models of AD show impaired neurogenesis. To determine how neurogenesis is affected in the brains of patients with AD, we investigated the expression of immature neuronal marker proteins that signal the birth of new neurons in the hippocampus of AD patients. Compared to controls, Alzheimer's brains showed increased expression of doublecortin, polysialylated nerve cell adhesion molecule, neurogenic differentiation factor and TUC-4. Expression of doublecortin and TUC-4 was associated with neurons in the neuroproliferative (subgranular) zone of the dentate gyrus, the physiological destination of these neurons (granule cell layer), and the CA1 region of Ammon's horn, which is the principal site of hippocampal pathology in AD. These findings suggest that neurogenesis is increased in AD hippocampus, where it may give rise to cells that replace neurons lost in the disease, and that stimulating hippocampal neurogenesis might provide a new treatment strategy.

UR - http://www.scopus.com/inward/record.url?scp=0346458659&partnerID=8YFLogxK

U2 - 10.1073/pnas.2634794100

DO - 10.1073/pnas.2634794100

M3 - Article

C2 - 14660786

AN - SCOPUS:0346458659

VL - 101

SP - 343

EP - 347

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 1

ER -